Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Active site plasticity and possible modes of chemical inhibition of the human DNA deaminase APOBEC3B

Journal Article · · FASEB BioAdvances
 [1];  [2];  [1];  [3];  [1];  [2];  [1];  [1]
  1. Univ. of Minnesota, Minneapolis, MN (United States)
  2. Univ. of California, San Diego, La Jolla, CA (United States)
  3. Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS), Northeastern Collaborative Access Team; Cornell Univ., Ithaca, NY (United States)

The single-stranded DNA cytosine deaminase APOBEC3B (A3B) functions in innate immunity against viruses, but it is also strongly implicated in eliciting mutations in cancer genomes. Because of the critical role of A3B in promoting virus and tumor evolution, small molecule inhibitors are desirable. However, there is no reported structure for any of the APOBEC3-family enzymes in complex with a small molecule bound in the active site, which hampers the development of small molecules targeting A3B. Here we report high-resolution structures of an active A3B catalytic domain chimera with loop 7 residues exchanged with those from the corresponding region of APOBEC3G (A3G). The structures reveal novel open conformations lacking the catalytically essential zinc ion, with the highly conserved active site residues extensively rearranged. These inactive conformations are stabilized by 2-pyrimidone or an iodide ion bound in the active site. Molecular dynamics simulations corroborate the remarkable plasticity of the engineered active site and identify key interactions that stabilize the native A3B active site. These data provide insights into A3B active site dynamics and suggest possible modes of its inhibition by small molecules, which would aid in rational design of selective A3B inhibitors for constraining virus and tumor evolution.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); National Science Foundation (NSF); USDOE Office of Science (SC)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1606455
Journal Information:
FASEB BioAdvances, Journal Name: FASEB BioAdvances Journal Issue: 1 Vol. 2; ISSN 2573-9832
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (56)

The Amber biomolecular simulation programs journal January 2005
Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers journal August 2014
Inhibition of the lymphoid tyrosine phosphatase: The effect of zinc(II) ions and chelating ligand fragments on enzymatic activity journal August 2014
APOBEC Enzymes as Targets for Virus and Cancer Therapy journal January 2018
The Local Dinucleotide Preference of APOBEC3G Can Be Altered from 5′-CC to 5′-TC by a Single Amino Acid Substitution journal November 2013
1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal Structure journal June 2016
Crystal Structure of the APOBEC3G Catalytic Domain Reveals Potential Oligomerization Interfaces journal January 2010
Sticky fingers: zinc-fingers as protein-recognition motifs journal February 2007
DNA Deamination Mediates Innate Immunity to Retroviral Infection journal June 2003
Zinc finger proteins: new insights into structural and functional diversity journal February 2001
Determinants of Oligonucleotide Selectivity of APOBEC3B journal August 2018
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB journal July 2015
Small-molecule inhibition of HIV-1 Vif journal September 2008
The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis journal September 2016
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity journal April 2017
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer journal April 2014
An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers journal August 2015
Human cells clear foreign DNA journal February 2010
Mechanisms underlying mutational signatures in human cancers journal July 2014
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA journal June 2018
APOBEC restriction goes nuclear journal December 2018
Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B journal December 2017
Innate Immune Signaling Induces High Levels of TC-specific Deaminase Activity in Primary Monocyte-derived Cells through Expression of APOBEC3A Isoforms journal July 2010
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution journal March 2018
Structural classification of zinc fingers: SURVEY AND SUMMARY journal January 2003
Phaser crystallographic software journal July 2007
XDS journal January 2010
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer journal October 2016
Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses journal May 2016
APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma journal October 2013
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity journal June 2015
PHENIX: a comprehensive Python-based system for macromolecular structure solution. text January 2010
The structure of Escherichia coli cytosine deaminase 1 1Edited by I. A. Wilson journal January 2002
DNA Deamination Mediates Innate Immunity to Retroviral Infection journal June 2003
Zinc finger proteins: new insights into structural and functional diversity journal February 2001
Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands journal August 2018
APOBEC3B is an enzymatic source of mutation in breast cancer journal February 2013
Enhancing immunity to HIV through APOBEC journal October 2008
Mechanisms of human lymphoid chromosomal translocations journal May 2016
Hypermutation in human cancer genomes: footprints and mechanisms journal November 2014
APOBEC3 proteins mediate the clearance of foreign DNA from human cells journal January 2010
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B journal December 2016
Epstein–Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity journal November 2018
Innate Immune Signaling Induces High Levels of TC-specific Deaminase Activity in Primary Monocyte-derived Cells through Expression of APOBEC3A Isoforms journal July 2010
Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain journal September 2015
Crystal Structure of Yeast Cytosine Deaminase: INSIGHTS INTO ENZYME MECHANISM AND EVOLUTION journal March 2003
Inhibition of Cytidine Deaminase by Derivatives of 1-(β-D-Ribofuranosyl)-Dihydropyrimidin-2-One (Zebularine) journal December 1992
Protein motifs 5. Zinc fingers. journal May 1995
Phaser crystallographic software journal July 2007
XDS journal January 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses journal May 2016
Human Papillomavirus E6 Triggers Upregulation of the Antiviral and Cancer Genomic DNA Deaminase APOBEC3B journal October 2014
APOBEC3B Upregulation and Genomic Mutation Patterns in Serous Ovarian Carcinoma journal October 2013
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity journal June 2015